Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             47 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®) Zanon, Ezio

195 C p. 125-127
artikel
2 Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes Shaw, Joseph R.

195 C p. 21-28
artikel
3 A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism Friberg, Leif

195 C p. 238-242
artikel
4 A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism Piazza, Gregory

195 C p. 169-170
artikel
5 A multicenter reference interval study of thromboelastography in the Chinese adult population Zeng, Xianfei

195 C p. 180-186
artikel
6 Antithrombotic “in vivo” effects of quercetin 3,7,3’,4’-tetrasulfate isolated from Flaveria bidentis in an experimental thrombosis model in mice Guglielmone, Hugo A.

195 C p. 190-192
artikel
7 Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis Nithianandan, Harrish

195 C p. 195-208
artikel
8 Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Siguret, Virginie

195 C p. 74-76
artikel
9 Assessment of rotational thrombelastometry (ROTEM) parameters in hepatocellular carcinoma Seeßle, Jessica

195 C p. 55-57
artikel
10 A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models Ripsman, David

195 C p. 103-113
artikel
11 Biallelic variants in PROZ as a cause of hypercoagulability and livedo racemosa Pinto e Vairo, Filippo

195 C p. 187-189
artikel
12 Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study Luan, Ying-yi

195 C p. 62-68
artikel
13 Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019 Hightower, Stephanie

195 C p. 69-71
artikel
14 Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case Hindilerden, Fehmi

195 C p. 136-138
artikel
15 D-dimer level is associated with the severity of COVID-19 Yu, Hai-Han

195 C p. 219-225
artikel
16 Determinants of left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation Han, Deheng

195 C p. 233-237
artikel
17 Diagnostic performance of coagulation indices for direct oral anticoagulant concentration Zhang, Hanxu

195 C p. 171-179
artikel
18 Editorial Board
195 C p. IFC
artikel
19 Erythrocyte-rich thrombi related to serum iron contribute to single stent retrieval and favorable clinical outcomes in acute ischemic stroke by endovascular treatment Liu, Mingli

195 C p. 8-15
artikel
20 Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care Thomas, W.

195 C p. 226-227
artikel
21 Immature platelets: a review of the available evidence Benlachgar, Naoufal

195 C p. 43-50
artikel
22 Incidence and prevalence of venous thromboembolism in Norway 2010–2017 Ghanima, Waleed

195 C p. 165-168
artikel
23 Increased levels of platelet-derived microparticles in pulmonary hypertension Ogawa, Aiko

195 C p. 120-124
artikel
24 Innate coagulability changes with age in stored packed red blood cells Pulliam, Kasiemobi E.

195 C p. 35-42
artikel
25 In vitro hemocompatibility testing of medical devices Nalezinková, Martina

195 C p. 146-150
artikel
26 Longitudinal analysis of extracellular vesicle-associated tissue factor activity in cancer patients Reitter, Eva-Maria

195 C p. 215-218
artikel
27 Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia Lecumberri, Ramón

195 C p. 139-145
artikel
28 Management of high-risk pulmonary embolism in an “unstable medical environment”: Not only a matter of hemodynamic Zuin, Marco

195 C p. 193-194
artikel
29 Novel assay based on diluted prothrombin time reflects anticoagulant effects of direct oral factor Xa inhibitors: Results of multicenter study in Japan Ieko, Masahiro

195 C p. 158-164
artikel
30 Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A Ebbert, Patrick T.

195 C p. 51-54
artikel
31 Predicting bleeding risk by simplified PRECISE-DAPT score Choi, Sun Young

195 C p. 72-73
artikel
32 Pulmonary embolism in hospitalised patients with COVID-19 Whyte, Martin B.

195 C p. 95-99
artikel
33 Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial Eichinger, Sabine

195 C p. 209-214
artikel
34 Rewarming from accidental hypothermia enhances whole blood clotting properties in a murine model Horioka, Kie

195 C p. 114-119
artikel
35 Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism Yuriditsky, Eugene

195 C p. 29-34
artikel
36 Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis Sambola, Antonia

195 C p. 128-135
artikel
37 Small procoagulant platelets in diabetes type 2 Edvardsson, Maria

195 C p. 1-7
artikel
38 Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation Correale, Michele

195 C p. 16-20
artikel
39 TFPIα alleviated vascular endothelial cell injury by inhibiting autophagy and the class III PI3K/Beclin-1 pathway Zhao, Yong

195 C p. 151-157
artikel
40 The antithrombotic effect of caffeic acid is associated with a cAMP-dependent pathway and clot retraction in human platelets Nam, Gi Suk

195 C p. 87-94
artikel
41 The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants Lee, Ji Yun

195 C p. 243-249
artikel
42 The reversed halo sign: Considerations in the context of the COVID-19 pandemic Marchiori, Edson

195 C p. 228-230
artikel
43 Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism Kovacs, Matthew R.

195 C p. 231-232
artikel
44 Thromboprophylaxis after renal transplantation and patient risk stratification: The case of mTOR inhibitors Jara-Palomares, Luis

195 C p. 100-102
artikel
45 Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism Schwab-Daugherty, Elyse M.

195 C p. 58-61
artikel
46 Venous thromboembolism after fast-track unicompartmental knee arthroplasty – A prospective multicentre cohort study of 3927 procedures Petersen, Pelle Baggesgaard

195 C p. 81-86
artikel
47 Von Willebrand factor, ABO blood group, and risk of first-ever intracerebral hemorrhage: A prospective nested case-control study Johansson, Kristina

195 C p. 77-80
artikel
                             47 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland